Journals / Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi / 2020 / Cilt: 23 - Sayı: 2

Pulmonary Rehabilitation Principles After SARS-CoV-2 (COVID-19): A Guideline for the Management of Acute and Subacute Course

SARS-CoV-2 (COVID-19) Sonrası Pulmoner Rehabilitasyon Prensipleri: Akut ve Subakut Sürecin Yönetimi İçin Rehber

Pages
111–123
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this guideline, the contagiousness of COVID-19, recommendations on limited contact of patient with health care providers, and the evidence about possible benefits of PR were taken into consideration.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Coronavirus disease 2019 (COVID-19) is a contagious infection disease, which may cause respiratory, physical, psycological and generalised systemic dysfunction.
📊
Key Findings & Data:COVID-19 affects the pulmonary system crucially.
💡
Conclusion & Impact:In this guideline, the contagiousness of COVID-19, recommendations on limited contact of patient with health care providers, and the evidence about possible benefits of PR were taken into consideration.
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Domain Parameters

Abstract

Coronavirus disease 2019 (COVID-19) is a contagious infection disease, which may cause respiratory, physical, psycological and generalised systemic dysfunction. The severity of disease ranges from an asymptomatic infection, mild illness, mild or severe pneumonia with respiratory failure, acute respiratory distress syndrome and/or death. COVID-19 affects the pulmonary system crucially. There is a lack of knowledge about the longterm outcomes of the disease and the possible sequeles and rehabilitation, as well. This clinical practice guideline includes pulmonary rehabilitation (PR) recommendations for adult COVID-19 patients and is developed in the light of the guides on the diagnosis and treatment of COVID-19 provided by World Health Organisation and Turkish Republic Ministery of Health, and recently published scientific literature, PR recommendations for COVID-19 regarding basic principles of PR. In this guideline, the contagiousness of COVID-19, recommendations on limited contact of patient with health care providers, and the evidence about possible benefits of PR were taken into consideration.

Özet

Coronavirus Hastalığı 2019 (COVID-19) solunumsal, fiziksel, psikolojik ve yaygın sistemik işlev bozukluğuna yol açabilen bulaşıcı bir hastalıktır. Hastalığın ciddiyeti asemptomatik enfeksiyondan, hafif hastalık, pnömoni, ciddi pnömoni, akut solunum sıkıntısı sendromu, solunum yetmezliği ve ölüme kadar değişebilmektedir. COVID-19 solunum sistemi önemli şekilde etkilenmektedir. Hastalığın uzun dönem sonuçları ve muhtemel sekellerine ilişkin yeterli bilgi olmadığı gibi, rehabilitasyonu konusunda da henüz kanıt yoktur. Bu klinik uygulama rehberi erişkin COVID-19 hastaları için pulmoner rehabilitasyon önerileri içermektedir ve Dünya Sağlık Örgütü ile T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü tarafından hazırlanan COVID-19 tanı ve tedavi rehberleri, yakın zamanlı bilimsel yayınlar, uzman görüşü olarak yayınlanan COVID-19 için pulmoner rehabilitasyon önerileri ışığında ve pulmoner rehabilitasyonun temel prensipleri doğrultusunda hazırlanmıştır Bu öneriler geliştirilirken, COVID-19’un bulaşıcılığı, sınırlı sayıda personelin hasta ile teması ilkeleri ile pulmoner rehabilitasyonun sağlayacağı yararların düzeyi göz önünde bulundurulmuştur.

🔖

Cite This Article

AYTÜR, Y. K., KÖSEOĞLU, B., TAŞKIRAN, Ö. Ö., GÖKKAYA, N. K. O., DELİALİOĞLU, S. Ü., TUR, B. S., SARIKAYA, S., ARIKAN, H., TİFTİK, T. T., ALEMDAROĞLU, E., AYHAN, F. F., ÇAKIT, B. D., GENÇ, A., GÜNDOĞDU, İ., GÜZEL, R., KABAYEL, D. D. (2020). Pulmonary Rehabilitation Principles After SARS-CoV-2 (COVID-19): A Guideline for the Management of Acute and Subacute Course. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi, Cilt: 23 - Sayı: 2, 111–123. https://ajindex.com/articles/199751

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü. COvID-19 (SARS-Cov-2 Enfeksiyonu) Rehberi (Bilim Kurulu Çalışması). Ankara: T.C. Sağlık Bakanlığı; 2020. p.89. [Link] 2. World Health Organization (WHO). Coronavirus Disease 2019 (Covid-19) Technical Guidance. [Link] 3. Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J virol. 2005:79:14614-21. [Crossref] [PubMed] [PMC] 4. Wan Y, Shang J, Graham R, et al. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J virol. 2020;94:e00127-20. [Crossref] [PubMed] [PMC] 5. Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020:579:270-3. [PubMed] 6. Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCov spike in the prefusion conformation. Science. 2020;367:1260- 3. [Crossref] [PubMed] [PMC] 7. Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000;87:E1-9. [Crossref] [PubMed] 8. Tortorici MA, veesler D. Structural insights into coronavirus entry. Adv virus Res. 2019;105:93-116. [Crossref] [PubMed] [PMC] 9. de Wilde AH, Snijder EJ, Kikkert M, et al. Host factors in coronavirus replication. Curr Top Microbiol Immunol. 2018;419:1-42. [Crossref] [PubMed] [PMC] 10. Sawicki SG, Sawicki DL. Coronavirus transcription: a perspective. Curr Top Microbiol Immunol. 2005;287:31-55. [Crossref] [PubMed] [PMC] 11. Hussain S, Pan J, Chen Y, et al. Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. J virol. 2005;79:5288-95. [Crossref] [PubMed] [PMC] 12. Tian S, Hu W, Niu L, et al. Pulmonary pathology of early-phase 2019 novel coronavirus (COvID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020 Feb 28. Online ahead of print. [Crossref] [PubMed] [PMC] 13. Jin YH, Cai L, Cheng ZS, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCov) infected pneumonia (standard version). Mil Med Res. 2020;7:4. [PubMed] 14. Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COvID-19) outbreak-an update on the status. Mil Med Res. 2020;7:11. [Crossre